Skip to Main Content

Paper Details

Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning.
Brief Bioinform
50
2018
RepurposeDB, Zika virus, arterial hypertension, chronic diseases, cisplatin, cisplatin-resistant ovarian cancer, diseases, drug, drug-resistant cancers, infectious diseases
Author NameAffiliation
Khader ShameerInstitute of Next Generation Healthcare
Khader ShameerInstitute of Next Generation Healthcare
Benjamin S GlicksbergIcahn School of Medicine at Mount Sinai
Benjamin S GlicksbergIcahn School of Medicine at Mount Sinai
Rachel A HodosIcahn School of Medicine at Mount Sinai
Rachel A HodosNew York University
Kipp W JohnsonIcahn School of Medicine at Mount Sinai
Marcus A BadgeleyIcahn School of Medicine at Mount Sinai
Ben ReadheadInstitute of Next Generation Healthcare
Max S TomlinsonInstitute of Next Generation Healthcare
Timothy O'ConnorBoston College
Riccardo MiottoInstitute of Next Generation Healthcare
Riccardo MiottoInstitute of Next Generation Healthcare
Brian A KiddInstitute of Next Generation Healthcare
Rong ChenClinical Genome Informatics, Icahn Institute of Genetics and Multiscale Biology
Avi Ma'ayanMount Sinai Center for Bioinformatics
Avi Ma'ayanMount Sinai Center for Bioinformatics
Joel T DudleyInstitute of Next Generation Healthcare
Joel T Dudley
Joel T Dudley
Joel T DudleyIcahn School of Medicine at Mount Sinai
Joel T DudleyInstitute of Next Generation Healthcare
Joel T Dudley
Joel T Dudley
Joel T DudleyIcahn School of Medicine at Mount Sinai
  • 1 - 25

Datasets

Release 1.2